Kamilla W Miskowiak

Summary

Publications

  1. doi request reprint The search for neuroimaging and cognitive endophenotypes: A critical systematic review of studies involving unaffected first-degree relatives of individuals with bipolar disorder
    Kamilla W Miskowiak
    Copenhagen Affective Disorder Research Centre, Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark Electronic address
    Neurosci Biobehav Rev 73:1-22. 2016
  2. doi request reprint Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin
    Kamilla Woznica Miskowiak
    Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    J Clin Psychiatry 77:e1639-e1646. 2016
  3. doi request reprint Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field
    K W Miskowiak
    Copenhagen Psychiatric Centre, Copenhagen University Hospital, Rigshospitalet, Denmark Electronic address
    Eur Neuropsychopharmacol 26:1845-1867. 2016
  4. doi request reprint Cognitive enhancement treatments for bipolar disorder: A systematic review and methodological recommendations
    Kamilla W Miskowiak
    Copenhagen Psychiatric Centre, Copenhagen University Hospital, Rigshospitalet, Denmark Electronic address
    Eur Neuropsychopharmacol 26:1541-61. 2016
  5. doi request reprint Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders
    Kamilla W Miskowiak
    Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark Electronic address
    Biol Psychiatry 78:270-7. 2015
  6. ncbi request reprint 'Hot' cognition in major depressive disorder: a systematic review
    Kamilla W Miskowiak
    Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshos pitalet, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    CNS Neurol Disord Drug Targets 13:1787-803. 2014
  7. doi request reprint Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial
    Kamilla W Miskowiak
    Department of Psychiatry, Copenhagen Psychiatric Centre, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    J Clin Psychiatry 75:1347-55. 2014
  8. doi request reprint Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients
    Kamilla W Miskowiak
    Department of Psychiatry, Copenhagen University Hospital, Hans Kirks Vej 6, DK 2200, Copenhagen, Denmark
    Psychopharmacology (Berl) 210:419-28. 2010
  9. doi request reprint Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression
    Kamilla W Miskowiak
    Clinic for Affective Disorders, Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet 6211, Blegdamsvej 9, 2100 Copenhagen, Denmark
    Psychopharmacology (Berl) 219:687-98. 2012
  10. doi request reprint Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study
    Kamilla W Miskowiak
    Department of Psychiatry, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark
    Psychopharmacology (Berl) 207:133-42. 2009

Collaborators

Detail Information

Publications22

  1. doi request reprint The search for neuroimaging and cognitive endophenotypes: A critical systematic review of studies involving unaffected first-degree relatives of individuals with bipolar disorder
    Kamilla W Miskowiak
    Copenhagen Affective Disorder Research Centre, Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark Electronic address
    Neurosci Biobehav Rev 73:1-22. 2016
    ....
  2. doi request reprint Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin
    Kamilla Woznica Miskowiak
    Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    J Clin Psychiatry 77:e1639-e1646. 2016
    ....
  3. doi request reprint Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field
    K W Miskowiak
    Copenhagen Psychiatric Centre, Copenhagen University Hospital, Rigshospitalet, Denmark Electronic address
    Eur Neuropsychopharmacol 26:1845-1867. 2016
    ..Together, these strategies may improve the success of future cognition trials in MDD...
  4. doi request reprint Cognitive enhancement treatments for bipolar disorder: A systematic review and methodological recommendations
    Kamilla W Miskowiak
    Copenhagen Psychiatric Centre, Copenhagen University Hospital, Rigshospitalet, Denmark Electronic address
    Eur Neuropsychopharmacol 26:1541-61. 2016
    ..Future implementation of a 'neurocircuitry-based' biomarker model to evaluate neural target engagement is warranted. ..
  5. doi request reprint Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders
    Kamilla W Miskowiak
    Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark Electronic address
    Biol Psychiatry 78:270-7. 2015
    ..Erythropoietin (EPO) increases neuroplasticity and reduces cognitive difficulties in treatment-resistant depression (TRD) and remitted BD. This magnetic resonance imaging study assessed the neuroanatomical basis for these effects...
  6. ncbi request reprint 'Hot' cognition in major depressive disorder: a systematic review
    Kamilla W Miskowiak
    Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshos pitalet, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    CNS Neurol Disord Drug Targets 13:1787-803. 2014
    ..Taken together, these findings suggest that abnormalities in 'hot' cognition may constitute a candidate neurocognitive endophenotype for depression...
  7. doi request reprint Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial
    Kamilla W Miskowiak
    Department of Psychiatry, Copenhagen Psychiatric Centre, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    J Clin Psychiatry 75:1347-55. 2014
    ..Erythropoietin has neurotrophic actions and aids neurocognitive function. The aim of the study was to investigate the potential of erythropoietin to treat cognitive dysfunction in bipolar disorder...
  8. doi request reprint Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients
    Kamilla W Miskowiak
    Department of Psychiatry, Copenhagen University Hospital, Hans Kirks Vej 6, DK 2200, Copenhagen, Denmark
    Psychopharmacology (Berl) 210:419-28. 2010
    ..The current study investigates the effects of Epo on the neural and cognitive response to emotional facial expressions in depressed patients...
  9. doi request reprint Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression
    Kamilla W Miskowiak
    Clinic for Affective Disorders, Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet 6211, Blegdamsvej 9, 2100 Copenhagen, Denmark
    Psychopharmacology (Berl) 219:687-98. 2012
    ..Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in animal models of acute and chronic neurodegenerative conditions and in patients with cognitive decline...
  10. doi request reprint Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study
    Kamilla W Miskowiak
    Department of Psychiatry, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark
    Psychopharmacology (Berl) 207:133-42. 2009
    ..Erythropoietin (Epo) has neurotrophic effects and may be a novel therapeutic agent in the treatment of depression. We have found antidepressant-like effects of Epo on emotional processing and mood in healthy volunteers...
  11. pmc Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
    Kamilla W Miskowiak
    Clinic for Affective Disorders, Department of Psychiatry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
    Trials 11:97. 2010
    ....
  12. doi request reprint Impaired down-regulation of negative emotion in self-referent social situations in bipolar disorder: A pilot study of a novel experimental paradigm
    Hanne L Kjærstad
    Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Dep 6233, Blegdamsvej 9, DK 2100 Rigshospitalet, Copenhagen, Denmark
    Psychiatry Res 238:318-25. 2016
    ..Findings highlight the novel social scenario paradigm as a sensitive test for detection of ER difficulties in BD...
  13. doi request reprint Screening for cognitive dysfunction in unipolar depression: Validation and evaluation of objective and subjective tools
    Caroline Vintergaard Ott
    Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet Dep 6233, Blegdamsvej 9, DK 2100 Copenhagen, Denmark Electronic address
    J Affect Disord 190:607-15. 2016
    ..The present study investigated the validity of two new instruments to screen for cognitive dysfunction in UD, and their associations with socio-occupational capacity...
  14. pmc Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial
    Kamilla W Miskowiak
    Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
    Neuropsychopharmacology 39:1399-408. 2014
    ..02). The findings of this exploratory study highlight EPO as an interesting compound for treatment-resistant depression, which deserves further investigation...
  15. doi request reprint Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: Associations with functional abilities
    Johan Høy Jensen
    Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet Department 6233, Blegdamsvej 9, DK 2100 Copenhagen, Denmark Electronic address
    J Affect Disord 205:378-386. 2016
    ..Neurocognitive impairment in remitted patients with bipolar disorder contributes to functional disabilities. However, the pattern and impact of these deficits are unclear...
  16. doi request reprint Impairment of executive function and attention predicts onset of affective disorder in healthy high-risk twins
    Maj Vinberg
    Psychiatric Centre Copenhagen, Rigshospitalet, University Hospital of Copenhagen, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    J Clin Psychiatry 74:e747-53. 2013
    ..To investigate whether measures of cognitive function can predict onset of affective disorder in individuals at heritable risk...
  17. doi request reprint Is there an association between subjective and objective measures of cognitive function in patients with affective disorders?
    Anne M Svendsen
    Department of Psychiatry, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
    Nord J Psychiatry 66:248-53. 2012
    ..The relationship between subjectively experienced and objectively measured cognitive function is controversial with several studies reporting no correlation between subjective and objective deficits...
  18. doi request reprint The effect of erythropoietin on cognition in affective disorders - Associations with baseline deficits and change in subjective cognitive complaints
    Caroline Vintergaard Ott
    Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet Dep 6233, Blegdamsvej 9, DK 2100 Copenhagen, Denmark Electronic address
    Eur Neuropsychopharmacol 26:1264-73. 2016
    ..In conclusion, pro-cognitive effects of EPO occurred across affective disorders. Neuropsychological screening for cognitive dysfunction may be warranted in future cognition trials. ..
  19. pmc Effects of Short-Term Cognitive Remediation on Cognitive Dysfunction in Partially or Fully Remitted Individuals with Bipolar Disorder: Results of a Randomised Controlled Trial
    Kirsa M Demant
    Copenhagen Affective Disorder Clinic, Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
    PLoS ONE 10:e0127955. 2015
    ..The present study aimed to investigate the effects of CR on persistent cognitive dysfunction in BD...
  20. doi request reprint Assessment of subjective and objective cognitive function in bipolar disorder: Correlations, predictors and the relation to psychosocial function
    Kirsa M Demant
    Clinic for Affective Disorders, Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK 2100 Copenhagen, Denmark Electronic address
    Psychiatry Res 229:565-71. 2015
    ..Our findings indicate that adequate assessment of cognition in the clinical treatment of BD and in drug trials targeting cognition requires implementation of not only subjective measures but also of objective neuropsychological tests. ..
  21. pmc Effects of cognitive remediation on cognitive dysfunction in partially or fully remitted patients with bipolar disorder: study protocol for a randomized controlled trial
    Kirsa M Demant
    Copenhagen Affective Disorder Clinic, Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
    Trials 14:378. 2013
    ..The aim of this trial is to investigate whether cognitive remediation, a new psychological treatment, improves cognitive function and, in turn, psychosocial function in patients with bipolar disorder in partial or full remission...
  22. doi request reprint Optimising screening for cognitive dysfunction in bipolar disorder: Validation and evaluation of objective and subjective tools
    Johan Høy Jensen
    Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet Dep 6233, Blegdamsvej 9, DK 2100, Copenhagen, Denmark
    J Affect Disord 187:10-9. 2015
    ..The objective was to validate and evaluate instruments to screen for and monitor cognitive impairments, and improve the understanding of the association between cognitive measures and socio-occupational capacity...